Rivastigmine (sold under the trade name Exelon among others) is a cholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and Parkinson's.The drug can be administered orally or via a transdermal patch; the latter form reduces the prevalence of side effects, which typically include nausea and vomiting.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Rivastigmine industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
1.5 mg Capsules
3 mg Capsules
4.5 mg Capsules
6 mg Capsules
2mg/ml Oral solution
Market Segment by Product Application
Alzheimer's disease
Parkinson's
Finally, the report provides detailed profile and data information analysis of leading company.
Novartis
Sun Pharmaceutical
Mylan Pharmaceuticals
Teva
Dr. Reddy's Laboratories
Orchid Healthcare
APOTEX
Alembic Pharmaceuticals
MACLEODS
Cadila Pharmaceuticals
Aurobindo Pharma
Ajanta Pharma
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Rivastigmine consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Rivastigmine market by identifying its various subsegments.
3.Focuses on the key global Rivastigmine manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Rivastigmine with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Rivastigmine submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Rivastigmine Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Rivastigmine Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Rivastigmine Segment by Type
2.1.1 1.5 mg Capsules
2.1.2 3 mg Capsules
2.1.3 4.5 mg Capsules
2.1.4 6 mg Capsules
2.1.5 2mg/ml Oral solution
2.2 Market Analysis by Application
2.2.1 Alzheimer's disease
2.2.2 Parkinson's
2.3 Global Rivastigmine Market Comparison by Regions (2017-2027)
2.3.1 Global Rivastigmine Market Size (2017-2027)
2.3.2 North America Rivastigmine Status and Prospect (2017-2027)
2.3.3 Europe Rivastigmine Status and Prospect (2017-2027)
2.3.4 China Rivastigmine Status and Prospect (2017-2027)
2.3.5 Japan Rivastigmine Status and Prospect (2017-2027)
2.3.6 Southeast Asia Rivastigmine Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Rivastigmine Industry Impact
2.5.1 Rivastigmine Business Impact Assessment - Covid-19
2.5.2 Market Trends and Rivastigmine Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Rivastigmine Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Rivastigmine Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Rivastigmine Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Rivastigmine Manufacturer Market Share
3.5 Top 10 Rivastigmine Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Rivastigmine Market
3.7 Key Manufacturers Rivastigmine Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Rivastigmine Industry Key Manufacturers
4.1 Novartis
4.1.1 Compan Detail
4.1.2 Novartis Rivastigmine Product Introduction, Application and Specification
4.1.3 Novartis 160 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Novartis News
4.2 Sun Pharmaceutical
4.2.1 Compan Detail
4.2.2 Sun Pharmaceutical Rivastigmine Product Introduction, Application and Specification
4.2.3 Sun Pharmaceutical Rivastigmine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Novartis News
4.3 Mylan Pharmaceuticals
4.3.1 Compan Detail
4.3.2 Mylan Pharmaceuticals Rivastigmine Product Introduction, Application and Specification
4.3.3 Mylan Pharmaceuticals Rivastigmine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Mylan Pharmaceuticals News
4.4 Teva
4.4.1 Compan Detail
4.4.2 Teva Rivastigmine Product Introduction, Application and Specification
4.4.3 Teva Rivastigmine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Teva News
4.5 Dr. Reddy's Laboratories
4.5.1 Compan Detail
4.5.2 Teva Rivastigmine Product Introduction, Application and Specification
4.5.3 Dr. Reddy's Laboratories Rivastigmine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Dr. Reddy's Laboratories News
4.6 Orchid Healthcare
4.6.1 Compan Detail
4.6.2 Orchid Healthcare Rivastigmine Product Introduction, Application and Specification
4.6.3 Orchid Healthcare Rivastigmine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Orchid Healthcare News
4.7 APOTEX
4.7.1 Compan Detail
4.7.2 APOTEX Rivastigmine Product Introduction, Application and Specification
4.7.3 APOTEX Rivastigmine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Alembic Pharmaceuticals
4.8.1 Compan Detail
4.8.2 Alembic Pharmaceuticals Rivastigmine Product Introduction, Application and Specification
4.8.3 Alembic Pharmaceuticals Rivastigmine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Alembic Pharmaceuticals News
4.9 MACLEODS
4.9.1 Compan Detail
4.9.2 MACLEODS Rivastigmine Product Introduction, Application and Specification
4.9.3 MACLEODS Rivastigmine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 MACLEODS News
4.10 Cadila Pharmaceuticals
4.10.1 Compan Detail
4.10.2 Cadila Pharmaceuticals Rivastigmine Product Introduction, Application and Specification
4.10.3 Cadila Pharmaceuticals Rivastigmine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Cadila Pharmaceuticals News
4.11 Aurobindo Pharma
4.11.1 Compan Detail
4.11.2 Aurobindo Pharma Rivastigmine Product Introduction, Application and Specification
4.11.3 Aurobindo Pharma Rivastigmine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Aurobindo Pharma News
4.12 Ajanta Pharma
4.12.1 Compan Detail
4.12.2 Ajanta Pharma Rivastigmine Product Introduction, Application and Specification
4.12.3 Ajanta Pharma Rivastigmine Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Ajanta Pharma News
5 Global Rivastigmine Market Segment by Big Type
5.1 Global Rivastigmine Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Rivastigmine Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Rivastigmine Revenue and Market Share by Big Type (2017-2022)
5.2 1.5 mg Capsules Sales Growth Rate and Price
5.2.1 Global 1.5 mg Capsules Sales Growth Rate (2017-2022)
5.2.2 Global 1.5 mg Capsules Price (2017-2022)
5.3 3 mg Capsules Sales Growth Rate and Price
5.3.1 Global 3 mg Capsules Sales Growth Rate (2017-2022)
5.3.2 Global 3 mg Capsules Price (2017-2022)
5.4 4.5 mg Capsules Sales Growth Rate and Price
5.4.1 Global 4.5 mg Capsules Sales Growth Rate (2017-2022)
5.4.2 Global 4.5 mg Capsules Price (2017-2022)
5.5 6 mg Capsules Sales Growth Rate and Price
5.5.1 Global 6 mg Capsules Sales Growth Rate (2017-2022)
5.5.2 Global 6 mg Capsules Price (2017-2022)
5.6 2mg/ml Oral solution Sales Growth Rate and Price
5.6.1 Global 2mg/ml Oral solution Sales Growth Rate (2017-2022)
5.6.2 Global 2mg/ml Oral solution Price (2017-2022)
6 Global Rivastigmine Market Segment by Big Application
6.1 Global Rivastigmine Sales Market Share by Big Application (2017-2022)
6.2 Alzheimer's disease Sales Growth Rate (2017-2022)
6.3 Parkinson's Sales Growth Rate (2017-2022)
7 Global Rivastigmine Forecast
7.1 Global Rivastigmine Revenue, Sales and Growth Rate (2022-2027)
7.2 Rivastigmine Market Forecast by Regions (2022-2027)
7.2.1 North America Rivastigmine Market Forecast (2022-2027)
7.2.2 Europe Rivastigmine Market Forecast (2022-2027)
7.2.3 China Rivastigmine Market Forecast (2022-2027)
7.2.4 Japan Rivastigmine Market Forecast (2022-2027)
7.2.5 Southeast Asia Rivastigmine Market Forecast (2022-2027)
7.2.6 Other Regions Rivastigmine Market Forecast (2022-2027)
7.3 Rivastigmine Market Forecast by Type (2022-2027)
7.3.1 Global Rivastigmine Sales Forecast by Type (2022-2027)
7.3.2 Global Rivastigmine Market Share Forecast by Type (2022-2027)
7.4 Rivastigmine Market Forecast by Application (2022-2027)
7.4.1 Global Rivastigmine Sales Forecast by Application (2022-2027)
7.4.2 Global Rivastigmine Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Rivastigmine Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Rivastigmine Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Rivastigmine
Figure Market Concentration Ratio and Market Maturity Analysis of Rivastigmine
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Rivastigmine Market Size by Big Type
Figure Global Market Share of Rivastigmine by Big Type in 2021
Figure 1.5 mg Capsules Picture (2017-2022)
Figure 3 mg Capsules Picture (2017-2022)
Figure 4.5 mg Capsules Picture (2017-2022)
Figure 6 mg Capsules Picture (2017-2022)
Global Rivastigmine Market Size by Big Application
Table Global Rivastigmine Market Size by Application
Figure Global Rivastigmine Market Share by Big Application in 2021
Figure Alzheimer's disease Picture
Figure Parkinson's Picture
Table Global Rivastigmine Comparison by Regions (M USD) (2017-2027)
Figure Global Rivastigmine Market Size (Million US$) (2017-2027)
Figure North America Rivastigmine Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Rivastigmine Revenue (Million US$) Growth Rate (2017-2027)
Figure China Rivastigmine Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Rivastigmine Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Rivastigmine Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Rivastigmine Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Rivastigmine Sales by Manufacturer (2017-2022)
Figure Global Rivastigmine Sales Market Share by Manufacturer in 2021
Table Global Rivastigmine Revenue by Manufacturer (2017-2022)
Figure Global Rivastigmine Revenue Market Share by Manufacturer in 2021
Table Global Rivastigmine Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Rivastigmine Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Rivastigmine Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Rivastigmine Market
Table Key Manufacturers Rivastigmine Product Type
Table Mergers & Acquisitions Planning
Table Novartis Company Profile
Table Rivastigmine Product Introduction, Application and Specification of Novartis
Table Rivastigmine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Sun Pharmaceutical Company Profile
Table Rivastigmine Product Introduction, Application and Specification of Sun Pharmaceutical
Table Rivastigmine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sun Pharmaceutical Recent Development
Table Mylan Pharmaceuticals Company Profile
Table Rivastigmine Product Introduction, Application and Specification of Mylan Pharmaceuticals
Table Rivastigmine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Mylan Pharmaceuticals Main Business
Table Mylan Pharmaceuticals Recent Development
Table Teva Company Profile
Table Rivastigmine Product Introduction, Application and Specification of Teva
Table Rivastigmine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Main Business
Table Teva Recent Development
Table Teva Main Business
Table Teva Recent Development
Table Dr. Reddy's Laboratories Company Profile
Table Rivastigmine Product Introduction, Application and Specification of Dr. Reddy's Laboratories
Table Rivastigmine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Dr. Reddy's Laboratories Main Business
Table Dr. Reddy's Laboratories Recent Development
Table Orchid Healthcare Company Profile
Table Rivastigmine Product Introduction, Application and Specification of Orchid Healthcare
Table Rivastigmine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Orchid Healthcare Main Business
Table Orchid Healthcare Recent Development
Table APOTEX Company Profile
Table Rivastigmine Product Introduction, Application and Specification of APOTEX
Table Rivastigmine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table APOTEX Main Business
Table APOTEX Recent Development
Table Alembic Pharmaceuticals Company Profile
Table Rivastigmine Product Introduction, Application and Specification of Alembic Pharmaceuticals
Table Rivastigmine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Alembic Pharmaceuticals Main Business
Table Alembic Pharmaceuticals Recent Development
Table MACLEODS Company Profile
Table Rivastigmine Product Introduction, Application and Specification of MACLEODS
Table Rivastigmine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table MACLEODS Main Business
Table MACLEODS Recent Development
Table Cadila Pharmaceuticals Company Profile
Table Rivastigmine Product Introduction, Application and Specification of Cadila Pharmaceuticals
Table Rivastigmine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cadila Pharmaceuticals Main Business
Table Cadila Pharmaceuticals Recent Development
Table Aurobindo Pharma Company Profile
Table Rivastigmine Product Introduction, Application and Specification of Aurobindo Pharma
Table Rivastigmine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Aurobindo Pharma Main Business
Table Aurobindo Pharma Recent Development
Table Ajanta Pharma Company Profile
Table Rivastigmine Product Introduction, Application and Specification of Ajanta Pharma
Table Rivastigmine Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Ajanta Pharma Main Business
Table Ajanta Pharma Recent Development
Figure Global Rivastigmine Sales and Growth Rate (2017-2022)
Figure Global Rivastigmine Revenue and Growth Rate (2017-2022)
Table Global Rivastigmine Sales by Regions (2017-2022)
Figure Global Rivastigmine Sales Market Share by Regions in 2021
Table Global Rivastigmine Revenue by Regions (2017-2022)
Figure Global Rivastigmine Revenue Market Share by Regions in 2021
Figure North America Rivastigmine Sales and Growth Rate (2017-2022)
Figure Europe Rivastigmine Sales and Growth Rate (2017-2022)
Figure China Rivastigmine Sales and Growth Rate (2017-2022)
Figure Japan Rivastigmine Sales and Growth Rate (2017-2022)
Figure Southeast Asia Rivastigmine Sales and Growth Rate (2017-2022)
Figure Other Regions Rivastigmine Sales and Growth Rate (2017-2022)
Table Global Rivastigmine Sales by Big Type (2017-2022)
Table Global Rivastigmine Sales Market Share by Big Type (2017-2022)
Figure Global Rivastigmine Sales Market Share by Big Type in 2019
Table Global Rivastigmine Revenue by Big Type (2017-2022)
Table Global Rivastigmine Revenue Market Share by Big Type (2017-2022)
Table Global Rivastigmine Revenue Market Share by Big Type in 2019
Figure Global 1.5 mg Capsules Sales Growth Rate (2017-2022)
Figure Global 1.5 mg Capsules Price (2017-2022)
Figure Global 3 mg Capsules Sales Growth Rate (2017-2022)
Figure Global 3 mg Capsules Price (2017-2022)
Figure Global 4.5 mg Capsules Sales Growth Rate (2017-2022)
Figure Global 4.5 mg Capsules Price (2017-2022)
Figure Global 6 mg Capsules Sales Growth Rate (2017-2022)
Figure Global 6 mg Capsules Price (2017-2022)
Table Global Rivastigmine Sales by Big Application (2017-2022)
Table Global Rivastigmine Sales Market Share by Big Application (2017-2022)
Figure Global Rivastigmine Sales Market Share by Big Application in 2019
Figure Global Alzheimer's disease Sales Growth Rate (2017-2022)
Figure Global Parkinson's Sales Growth Rate (2017-2022)
Figure Global Rivastigmine Sales and Growth Rate (2022-2027)
Figure Global Rivastigmine Revenue and Growth Rate (2022-2027)
Table Global Rivastigmine Sales Forecast by Regions (2022-2027)
Table Global Rivastigmine Market Share Forecast by Regions (2022-2027)
Figure North America Sales Rivastigmine Market Forecast (2022-2027)
Figure Europe Sales Rivastigmine Market Forecast (2022-2027)
Figure China Sales Rivastigmine Market Forecast (2022-2027)
Figure Japan Sales Rivastigmine Market Forecast (2022-2027)
Figure Southeast Asia Sales Rivastigmine Market Forecast (2022-2027)
Figure Other Regions Sales Rivastigmine Market Forecast (2022-2027)
Table Global Rivastigmine Sales Forecast by Type (2022-2027)
Table Global Rivastigmine Market Share Forecast by Type (2022-2027)
Table Global Rivastigmine Sales Forecast by Application (2022-2027)
Table Global Rivastigmine Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rivastigmine
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Rivastigmine Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Rivastigmine Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Rivastigmine Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Rivastigmine Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Rivastigmine Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Rivastigmine Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Rivastigmine Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Rivastigmine Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)